Aligos Therapeutics, Inc. (ALGS) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $88.53M | +26.3% |
| 2024 | $70.09M | -53.7% |
| 2023 | $151.53M | +3.3% |
| 2022 | $146.69M | -37.7% |
| 2021 | $235.37M | -11.3% |
| 2020 | $265.30M | +81.1% |
| 2019 | $146.52M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $88.53M | +26.3% |
| 2024 | $70.09M | -53.7% |
| 2023 | $151.53M | +3.3% |
| 2022 | $146.69M | -37.7% |
| 2021 | $235.37M | -11.3% |
| 2020 | $265.30M | +81.1% |
| 2019 | $146.52M | — |